Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | 87.13 |
| peg ratio | -0.42 |
| price to book ratio | 5.15 |
| price to sales ratio | 18.92 |
| enterprise value multiple | 77.24 |
| price fair value | 5.15 |
profitability ratios | |
|---|---|
| gross profit margin | 91.11% |
| operating profit margin | 16.54% |
| pretax profit margin | 23.77% |
| net profit margin | 21.68% |
| return on assets | 5.33% |
| return on equity | 6.34% |
| return on capital employed | 4.48% |
liquidity ratio | |
|---|---|
| current ratio | 7.97 |
| quick ratio | 7.76 |
| cash ratio | 4.18 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 315.80 |
| operating cycle | 462.84 |
| days of payables outstanding | 94.84 |
| cash conversion cycle | 368.01 |
| receivables turnover | 2.48 |
| payables turnover | 3.85 |
| inventory turnover | 1.16 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 49.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | 2.02 |
| cash per share | 20.49 |
| operating cash flow per share | 2.21 |
| free cash flow operating cash flow ratio | 0.92 |
| cash flow coverage ratios | 49.03 |
| short term coverage ratios | 49.03 |
| capital expenditure coverage ratio | 11.99 |
Frequently Asked Questions
Krystal Biotech, Inc. (KRYS) published its most recent earnings results on 04-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Krystal Biotech, Inc. (NASDAQ:KRYS)'s trailing twelve months ROE is 6.34%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Krystal Biotech, Inc. (KRYS) currently has a ROA of 5.33%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
KRYS reported a profit margin of 21.68% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.97 in the most recent quarter. The quick ratio stood at 7.76, with a Debt/Eq ratio of 0.00.